About Julie Cherrington
Form D filings for Actym Therapeutics in 2023 list Julie Cherrington as director.
Julie Cherrington first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Julie Cherrington in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Julie Cherrington works with at each company, as listed on that company's latest Form D.
Actym Therapeutics, Inc. · Form D, Jul 6, 2023
CT
Christopher Thanos
Chief Executive Officer and director
BC
Benjamin Chen
Director
RM
Ron Mazumder
Director
KD
Kanad Das
Director